MLTX
Price
$52.92
Change
+$2.48 (+4.92%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
3.36B
6 days until earnings call
NERV
Price
$1.92
Change
+$0.05 (+2.67%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
13.37M
11 days until earnings call
Interact to see
Advertisement

MLTX vs NERV

Header iconMLTX vs NERV Comparison
Open Charts MLTX vs NERVBanner chart's image
MoonLake Immunotherapeutics
Price$52.92
Change+$2.48 (+4.92%)
Volume$54.03K
Capitalization3.36B
Minerva Neurosciences
Price$1.92
Change+$0.05 (+2.67%)
VolumeN/A
Capitalization13.37M
MLTX vs NERV Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. NERV commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and NERV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (MLTX: $50.44 vs. NERV: $1.87)
Brand notoriety: MLTX and NERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 149% vs. NERV: 6%
Market capitalization -- MLTX: $3.2B vs. NERV: $13.08M
MLTX [@Biotechnology] is valued at $3.2B. NERV’s [@Biotechnology] market capitalization is $13.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileNERV’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • NERV’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLTX and NERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 3 TA indicator(s) are bullish while NERV’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 3 bullish, 6 bearish.
  • NERV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NERV is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -8.34% price change this week, while NERV (@Biotechnology) price change was -13.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

NERV is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.36B) has a higher market cap than NERV($13.4M). MLTX YTD gains are higher at: -6.851 vs. NERV (-15.826). NERV has higher annual earnings (EBITDA): 8.58M vs. MLTX (-168.14M). MLTX has more cash in the bank: 480M vs. NERV (17.3M). NERV has less debt than MLTX: NERV (0) vs MLTX (75.6M). MLTX (0) and NERV (0) have equivalent revenues.
MLTXNERVMLTX / NERV
Capitalization3.36B13.4M25,067%
EBITDA-168.14M8.58M-1,959%
Gain YTD-6.851-15.82643%
P/E RatioN/A2.33-
Revenue00-
Total Cash480M17.3M2,775%
Total Debt75.6M0-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXNERV
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHIP6.820.04
+0.59%
Seanergy Maritime Holdings Corp
AC37.020.01
+0.03%
Associated Capital Group
DKNG45.04-0.71
-1.55%
DraftKings
TRMD18.41-0.49
-2.59%
TORM plc
ERNA1.73-0.12
-6.39%
Ernexa Therapeutics Inc

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XNCR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-0.04%
XNCR - MLTX
46%
Loosely correlated
-4.58%
XENE - MLTX
45%
Loosely correlated
-0.68%
IDYA - MLTX
44%
Loosely correlated
-3.94%
CRNX - MLTX
44%
Loosely correlated
-2.26%
CLDX - MLTX
44%
Loosely correlated
-3.64%
More

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with DNLI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-2.09%
DNLI - NERV
34%
Loosely correlated
+1.17%
ANAB - NERV
33%
Poorly correlated
-1.72%
IDYA - NERV
32%
Poorly correlated
-3.94%
MLTX - NERV
31%
Poorly correlated
-0.04%
GBIO - NERV
31%
Poorly correlated
-0.23%
More